Table: Cosmos Pharmaceutical -Q1 group results
Oct 11 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Aug 31, 2021 Aug 31, 2020 May 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 189.41 189.16 750.00
(+15.0 pct)
Operating 8.56 10.66 33.20
(+51.7 pct)
Recurring 9.30 11.22 35.90
(+49.0 pct)
Net 6.24 7.49 25.00
(+48.3 pct)
EPS 157.68 yen 189.15 yen 631.33 yen
Ann Div 70.00 yen 80.00 yen
-Q2 div 27.50 yen 40.00 yen
-Q4 div 42.50 yen 40.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T